NOG Antikörper
Kurzübersicht für NOG Antikörper (ABIN7135265)
Target
Alle NOG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    
- 
                                            
Kreuzreaktivität
 - Human, Maus, Ratte
 - 
                                            
Aufreinigung
 - Antigen Affinity purified
 - 
                                            
Immunogen
 - Human NOG
 - 
                                            
Isotyp
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - Optimal working dilution should be determined by the investigator.
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Buffer
 - PBS with 0.02 % Sodium Azide, 50 % Glycerol, pH 7.3. -20 °C, Avoid freeze / thaw cycles.
 - 
                                            
Konservierungsmittel
 - Sodium azide
 - 
                                            
Vorsichtsmaßnahmen
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Lagerung
 - -20 °C,-80 °C
 - 
                                            
Informationen zur Lagerung
 - Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
 - 
                                            
 - 
    
- NOG (Noggin (NOG))
 - 
                                            
Andere Bezeichnung
 - NOG
 - 
                                            
Hintergrund
 - Nog antibody, NOGG_HUMAN antibody, Noggin antibody, SYM 1 antibody, SYM1 antibody, Symphalangism 1 (proximal) antibody, Synostoses (multiple) syndrome 1 antibody, SYNS 1 antibody, SYNS1 antibody
 - 
                                            
UniProt
 - Q13253
 - 
                                            
Pathways
 - Stem Cell Maintenance, Tube Formation
 
Target
 -